Dr George D Smalls, MD in Gary, IN - Urology

Dr George D Smalls, MD is a Urology physician based in Gary, Indiana. Dr George D Smalls is licensed to practice in Indiana (license number 01026488) and his current practice location is 3229 Broadway, Suite 153, Gary, Indiana. He can be reached at his office (for appointments etc.) via phone at (219) 887-9077.

NPI number for Dr George D Smalls is 1912907288 and his current mailing address is 3229 Broadway, Suite 153, Gary, Indiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1912907288.

Contact Information

	Dr George D Smalls, MD
	3229 Broadway, Suite 153, Gary, IN 46409-1036
	(219) 887-9077
	(219) 887-0604

Physician's Profile

Full Name	Dr George D Smalls
Gender	Male
Speciality	Urology
Location	3229 Broadway, Gary, Indiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1912907288
Provider Enumeration Date: 07/28/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr George D Smalls such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912907288	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	01026488 (Indiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr George D Smalls is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr George D Smalls, MD 3229 Broadway, Suite 153, Gary, IN 46409-1036 Ph: (219) 887-9077	Dr George D Smalls, MD 3229 Broadway, Suite 153, Gary, IN 46409-1036 Ph: (219) 887-9077

News Archive

Bortezomib can improve control of GVHD and immune system recovery

A drug that has become a mainstay of multiple myeloma treatment may outperform alternative therapies in re-establishing the immune system of patients who have received stem cell transplants from unrelated, partially matched donors, according to early clinical trial results to be presented by Dana-Farber Cancer Institute investigators at the American Society of Hematology's (ASH) annual meeting on Sunday, Dec. 6 (Abstract 48, Ernest N. Morial Convention Center, Room 243-245, 5:45 pm CT).

Risperdal lawsuit settlement: Largest Medicaid fraud case in Texas

Texas and Janssen Pharmaceuticals reach a $158 million settlement on a suit claiming that the company lied about the efficacy of the anti-psychotic medicine.

DePuy Spine, Lanx, Medtronic, Zimmer Spine and Codman support NREF's post-residency clinical fellowships

The NREF has reached agreements with Medtronic, Lanx and Zimmer Spine to provide funding to the NREF in support of the Foundation's post-residency clinical fellowship grant program. The NREF is pleased to report that it has renewed its agreements with Codman & Shurtleff, Inc. and DePuy Spine, Inc., who supported the inaugural year of the fellowship program in 2010.

MAOA gene appears to make women happy

A new study has found a gene that appears to make women happy, but it doesn't work for men. The finding may help explain why women are often happier than men, the research team said.

New research alters concept of how circadian clock functions

Scientists from the University of Cambridge have identified a molecule that may govern how the circadian clock in plants responds to environmental changes.

Dr George D Smalls, MD - Urology in Gary, IN